Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | -7.83% | -1.29% | +7.75% |
May. 15 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
Feb. 14 | Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.75% | 17.04M | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Sector Update: Health Care Stocks Sputtering Ahead at Wednesday Close